+31 (0)317 466 260 info@amrif.eu

Supervisory Board

Bert Tournois, PhD

Dr. Tournois Started his professional carreer in the research institute ATO-DLO (1989-2000) where he held various management positions, eventually becoming director of the Business Units Food and Non Food technology. In 2005 he joined the institute directorate as commercial director. In 2000 he founded TDI, a Venture Catalyst Company and since then over 30 startups in medical, agrotechnology and food among which are companies TOP, Holland Food Ventures, Chez Pascal, Ojah, Phycom, Medlogics, Cool Wave Processing. At present he is private investor and business developer.

Ton Bolier, MSc

Ton Bolier has been active as a psychiatrist in mental health care for over 20 years. During his medical practice, he became involved in the support and management of startups. Since the late 90’s this has become his primary activity. Ton Bolier joined the Supervisory Board of AMRIF since its incorporation.

Frans van Duikeren

Frans van Duikeren has a degree in Food Technology (Wageningen UR) and management Consultancy (SIOO). Van Duikeren worked from 1978 until 2003 in the packaging industry, last fifteen years in general management in internationals. From 2004 van Duikeren started a small business consultancy company to support management of starting businesses and SME’s. From 2005 he also acts as an informal investor mainly in life sciences.

Paul Hamm

Paul Hamm has a degree in chemical technology (University of Delft) and has been active as initiator and founder of H&H Group, now BMA, a industry-equipment supply company. In 1997 Hamm was employed at DSM as director of acquisition, and next as Business group director at DSM Venturing & Business Development with business units in Europe, USA and Japan. From 2004 Hamm started an independent business with participations in several life sciences companies with focus on nutriceuticals and functional foods as well as an independent consultancy with activities focus on implementation of innovative know-how and value creation.

Daan van den Noort MD

Daan van den Noort has over 30 years of experience as a manager and venture capitalist in the pharmaceutical and biotech industry in Europe. His positions include being a General Manager at Genentech, Asta Medica and Ferring Pharmaceuticals in The Netherlands. From 2001 until 2011, he acted as Chief Investment Officer of the Biotech Turnaround Fund (BTF), a Dutch venture capital company. He served on the boards of several international investment companies active in the biopharmaceutical industry, holds external advisors hips with several national and international investment companies, and is a supervisory board member of several SME biotech companies such as Alloksys Life Sciences and AMRIF. Daan has an MD degree from the Free University of Amsterdam.